Cargando…
MDM2 Binding Protein Induces the Resistance of Hepatocellular Carcinoma Cells to Molecular Targeting Agents via Enhancing the Transcription Factor Activity of the Pregnane X Receptor
The MDM2 binding protein (MTBP) has been considered an important regulator of human malignancies. In this study, we demonstrate that the high level of MTBP’s endogenous expression is correlated with poor prognosis of advanced hepatocellular carcinoma (HCC) patients who received sorafenib. MTBP inter...
Autores principales: | Jiang, Qiyu, Ma, Yan, Han, Jingjing, Chu, Jingdong, Ma, Xuemei, Shen, Lijun, Liu, Bo, Li, Bo-an, Hou, Jun, Bi, Qian |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8264664/ https://www.ncbi.nlm.nih.gov/pubmed/34249768 http://dx.doi.org/10.3389/fonc.2021.715193 |
Ejemplares similares
-
Clinical Overview of MDM2/X-Targeted Therapies
por: Burgess, Andrew, et al.
Publicado: (2016) -
MDM2/X Inhibitors as Radiosensitizers for Glioblastoma Targeted Therapy
por: Miles, Xanthene, et al.
Publicado: (2021) -
Identification of pregnane-X receptor target genes and coactivator and corepressor binding to promoter elements in human hepatocytes
por: Hariparsad, Niresh, et al.
Publicado: (2009) -
Evolution of pharmacologic specificity in the pregnane X receptor
por: Ekins, Sean, et al.
Publicado: (2008) -
MTBP enhances the activation of transcription factor ETS-1 and promotes the proliferation of hepatocellular carcinoma cells
por: Wang, Hongbo, et al.
Publicado: (2022)